Showing results (291-300 of 341) with videos related to
Sort By:
Pageof 35
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2018
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR AnalysisWilliam A Wood, Ruta Brazauskas, Zhen-Huan Hu, et al.Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.Transplantation and Cellular Therapy|November 25, 2022
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation SurvivorsSanghee Hong, Jing Zhao, Shu Wang, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) DatabaseDimitrios P Kontoyiannis, Kieren A Marr, Benjamin J Park, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantationKaren K Ballen, Brent R Logan, Mary J Laughlin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2010
Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR)Alison W Loren, Eric Chow, David A Jacobsohn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.Pageof 35